The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human effort in the realm of scientific discovery, adding to a growing debate over its impact on medical research and innovation.
The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human effort in the realm of scientific discovery, adding to a growing debate over its impact on medical research and innovation.
<iframe src="https://statesidedaily.com/embed/cluster/901593f2ebfb6a4c656d536d19c1649b38a3b549" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Biotech Visionary Is Skeptical About AI’s Impact on Medical Innovation"></iframe>
